Boston Scientific (BSX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Boston Scientific Revenue Highlights

Latest Revenue (Y)

$16.75B

Latest Revenue (Q)

$4.66B

Main Segment (Y)

Cardiovascular

Main Geography (Y)

UNITED STATES

Boston Scientific Revenue by Period

Boston Scientific Revenue by Year

Date	Revenue	Change
2024-12-31	$16.75B	17.61%
2023-12-31	$14.24B	12.29%
2022-12-31	$12.68B	6.68%
2021-12-31	$11.89B	19.92%
2020-12-31	$9.91B	-7.66%
2019-12-31	$10.73B	9.28%
2018-12-31	$9.82B	8.57%
2017-12-31	$9.05B	7.89%
2016-12-31	$8.39B	12.16%
2015-12-31	$7.48B	1.31%
2014-12-31	$7.38B	3.32%
2013-12-31	$7.14B	-1.46%
2012-12-31	$7.25B	-4.89%
2011-12-31	$7.62B	-2.36%
2010-12-31	$7.81B	-4.67%
2009-12-31	$8.19B	1.71%
2008-12-31	$8.05B	-3.67%
2007-12-31	$8.36B	6.85%
2006-12-31	$7.82B	24.48%
2005-12-31	$6.28B	11.72%
2004-12-31	$5.62B	61.80%
2003-12-31	$3.48B	19.08%
2002-12-31	$2.92B	9.20%
2001-12-31	$2.67B	0.34%
2000-12-31	$2.66B	-6.26%
1999-12-31	$2.84B	27.24%
1998-12-31	$2.23B	19.30%
1997-12-31	$1.87B	28.06%
1996-12-31	$1.46B	32.07%
1995-12-31	$1.11B	146.60%
1994-12-31	$448.90M	-

Boston Scientific generated $16.75B in revenue during NA 2024, up 17.61% compared to the previous quarter, and up 156.00% compared to the same period a year ago.

Boston Scientific Revenue by Quarter

Date	Revenue	Change
2025-03-31	$4.66B	2.24%
2024-12-31	$4.56B	8.36%
2024-09-30	$4.21B	2.16%
2024-06-30	$4.12B	6.85%
2024-03-31	$3.86B	3.52%
2023-12-31	$3.73B	5.61%
2023-09-30	$3.53B	-2.00%
2023-06-30	$3.60B	6.20%
2023-03-31	$3.39B	4.53%
2022-12-31	$3.24B	2.27%
2022-09-30	$3.17B	-2.28%
2022-06-30	$3.24B	7.20%
2022-03-31	$3.03B	-3.23%
2021-12-31	$3.13B	6.65%
2021-09-30	$2.93B	-4.71%
2021-06-30	$3.08B	11.81%
2021-03-31	$2.75B	1.62%
2020-12-31	$2.71B	1.84%
2020-09-30	$2.66B	32.75%
2020-06-30	$2.00B	-21.23%
2020-03-31	$2.54B	-12.46%
2019-12-31	$2.90B	7.31%
2019-09-30	$2.71B	2.89%
2019-06-30	$2.63B	5.54%
2019-03-31	$2.49B	-2.66%
2018-12-31	$2.56B	7.02%
2018-09-30	$2.39B	-3.90%
2018-06-30	$2.49B	4.67%
2018-03-31	$2.38B	-1.20%
2017-12-31	$2.41B	8.37%
2017-09-30	$2.22B	-1.55%
2017-06-30	$2.26B	4.49%
2017-03-31	$2.16B	-1.41%
2016-12-31	$2.19B	4.09%
2016-09-30	$2.10B	-0.99%
2016-06-30	$2.13B	8.25%
2016-03-31	$1.96B	-0.71%
2015-12-31	$1.98B	4.77%
2015-09-30	$1.89B	2.44%
2015-06-30	$1.84B	4.24%
2015-03-31	$1.77B	-6.31%
2014-12-31	$1.89B	2.22%
2014-09-30	$1.85B	-1.44%
2014-06-30	$1.87B	5.58%
2014-03-31	$1.77B	-3.48%
2013-12-31	$1.84B	5.94%
2013-09-30	$1.74B	-4.09%
2013-06-30	$1.81B	2.73%
2013-03-31	$1.76B	-3.29%
2012-12-31	$1.82B	4.96%
2012-09-30	$1.74B	-5.09%
2012-06-30	$1.83B	-2.04%
2012-03-31	$1.87B	0.97%
2011-12-31	$1.85B	-1.39%
2011-09-30	$1.87B	-5.11%
2011-06-30	$1.98B	2.60%
2011-03-31	$1.93B	-3.85%
2010-12-31	$2.00B	4.49%
2010-09-30	$1.92B	-0.62%
2010-06-30	$1.93B	-1.63%
2010-03-31	$1.96B	-5.72%
2009-12-31	$2.08B	2.67%
2009-09-30	$2.02B	-2.36%
2009-06-30	$2.07B	3.18%
2009-03-31	$2.01B	0.40%
2008-12-31	$2.00B	1.21%
2008-09-30	$1.98B	-2.27%
2008-06-30	$2.02B	-1.08%
2008-03-31	$2.05B	-4.97%
2007-12-31	$2.15B	-

Boston Scientific generated $4.66B in revenue during Q1 2025, up 2.24% compared to the previous quarter, and up 125.18% compared to the same period a year ago.

Boston Scientific Revenue Breakdown

Boston Scientific Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
MedSurg	$5.99B	$5.42B	$5.06B	$3.72B	$3.07B
Cardiovascular	$10.76B	$8.82B	$8.16B	$4.86B	$3.88B
BSX Reportable Segments	-	-	$13.22B	$11.88B	$9.69B
Rhythm and Neuro	-	-	-	$3.29B	$2.75B

Boston Scientific's latest annual revenue breakdown by segment (product or service), as of Dec 24: Cardiovascular (64.22%), and MedSurg (35.78%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Dec 18
Cardiovascular	$3.08B	$2.94B	$2.73B	$2.05B	$2.13B	$2.06B	$2.07B	$1.90B	$1.27B	$1.20B	$1.26B	$1.13B	$1.01B	$1.00B	$834.00M	$1.03B	$1.01B	$1.03B	$972.00M	$971.00M
MedSurg	$1.58B	$1.62B	$1.48B	$1.25B	$1.35B	$1.26B	$1.28B	$1.16B	$999.00M	$917.00M	$948.00M	$860.00M	$891.00M	$825.00M	$576.00M	$774.00M	$845.00M	$818.00M	$766.00M	$800.00M
BSX Reportable Segments	-	-	-	$3.30B	$3.48B	$3.33B	$3.34B	$3.07B	$3.13B	$2.93B	$3.08B	$2.74B	$2.67B	$2.58B	$1.94B	$2.50B	-	-	-	-
Rhythm and Neuro	-	-	-	-	-	-	-	-	$857.00M	$819.00M	$866.00M	$750.00M	$767.00M	$757.00M	$525.00M	$703.00M	$780.00M	$786.00M	$757.00M	$789.00M
Specialty Pharmaceuticals	-	-	-	-	-	-	-	-	-	-	-	-	-	$74.00M	$68.00M	-	-	-	-	-
Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$68.00M	$41.00M	-	-	-	-
Excludes BTG Acquisition	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.64B	-	-	-

Boston Scientific's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Cardiovascular (66.17%), and MedSurg (33.83%).

Boston Scientific Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Emerging Markets	$2.68B	-	-	-	-
EMEA	$3.23B	$2.86B	$2.53B	-	-
JAPAN	$2.69B	-	-	-	-
UNITED STATES	$10.21B	$8.43B	$915.00M	$10.00M	$193.00M
Non-US	$6.54B	$5.82B	$103.00M	$4.00M	$27.00M
Latin America and Canada	$624.00M	$560.00M	$469.00M	-	-
Asia Pacific	-	$2.40B	$2.12B	-	-

Boston Scientific's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (39.32%), Non-US (25.18%), EMEA (12.43%), JAPAN (10.34%), Emerging Markets (10.32%), and Latin America and Canada (2.40%).

Quarterly Revenue by Country

Country	Mar 25	Dec 24	Sep 24	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
UNITED STATES	$1.49B	$6.76B	$1.27B	$265.00M	$253.00M	$234.00M	$225.00M	$203.00M	$303.00M	$275.00M	$285.00M	$10.00M	$31.00M	$65.00M	$60.00M	$37.00M	$268.00M	$257.00M	$248.00M	$231.00M
Non-US	$1.70B	$1.67B	$1.62B	$25.00M	$27.00M	$28.00M	$25.00M	$23.00M	$138.00M	$109.00M	$112.00M	$4.00M	$6.00M	$10.00M	$8.00M	$4.00M	$111.00M	$102.00M	$100.00M	$94.00M
Asia Pacific	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$410.00M	$409.00M	$496.00M	$484.00M	$481.00M	$437.00M
EMEA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$416.00M	$552.00M	$602.00M	$530.00M	$571.00M	$561.00M
Latin America and Canada	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$51.00M	$89.00M	$102.00M	$101.00M	$101.00M	$92.00M

Boston Scientific's latest quarterly revenue breakdown by geography, as of Mar 25: Non-US (53.30%), and UNITED STATES (46.70%).

Boston Scientific Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ABT	Abbott Laboratories	$41.95B	$10.36B
MDT	Medtronic	$32.36B	$8.29B
SYK	Stryker	$22.59B	$5.87B
BSX	Boston Scientific	$16.75B	$4.66B
SNN	Smith & Nephew	$5.55B	$2.79B
STE	STERIS	$5.46B	$1.37B
EW	Edwards Lifesciences	$5.44B	$1.41B
DXCM	DexCom	$3.62B	$1.04B
ZBH	Zimmer Biomet	$2.02B	$1.91B
ZIMV	ZimVie	$449.75M	$111.52M

BSX Revenue FAQ

What is Boston Scientific’s yearly revenue?

Boston Scientific's yearly revenue for 2024 was $16.75B, representing an increase of 17.61% compared to 2023. The company's yearly revenue for 2023 was $14.24B, representing an increase of 12.29% compared to 2022. BSX's yearly revenue for 2022 was $12.68B, representing an increase of 6.68% compared to 2021.

What is Boston Scientific’s quarterly revenue?

Boston Scientific's quarterly revenue for Q1 2025 was $4.66B, a 2.24% increase from the previous quarter (Q4 2024), and a 20.93% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $4.56B, a 8.36% increase from the previous quarter (Q3 2024), and a 22.44% increase year-over-year (Q4 2023). BSX's quarterly revenue for Q3 2024 was $4.21B, a 2.16% increase from the previous quarter (Q2 2024), and a 19.34% increase year-over-year (Q3 2023).

What is Boston Scientific’s revenue growth rate?

Boston Scientific's revenue growth rate for the last 3 years (2022-2024) was 32.05%, and for the last 5 years (2020-2024) was 68.94%.

What are Boston Scientific’s revenue streams?

Boston Scientific's revenue streams in c 24 are MedSurg, and Cardiovascular. MedSurg generated $5.99B in revenue, accounting 35.78% of the company's total revenue, up 10.53% year-over-year. Cardiovascular generated $10.76B in revenue, accounting 64.22% of the company's total revenue, up 21.95% year-over-year.

What is Boston Scientific’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Boston Scientific was Cardiovascular. This segment made a revenue of $10.76B, representing 64.22% of the company's total revenue.